Friday, February 10, 2006


Hep C Virus - SuperGen to buy drug developer for $18 Million


SuperGen to buy drug developer for $18 Million
San Jose Mercury News, USA - Jan 27, 2006... No other financial details were disclosed. Chronic HCV infection causes liver inflammation that can result in cirrhosis, liver cancer or liver failure. ...

Inovio and Tripep to develop hepatitis C vaccine
Pharmaceutical Business Review - Jan 17, 2006... The potential vaccine will be based on Tripep's proprietary hepatitis C virus (HCV) antigen and delivered to infected individuals using Inovio's medpulser DNA ...

Novel Role of Toll-Like Receptor 3 in Hepatitis C-Associated ...
Am J Pathology (subscription) - Feb 8, 2006Hepatitis C virus (HCV) infection is frequently complicated by glomerulonephritis with immune complexes containing viral RNA. We ...

Study of Hepatitis C Virus Solves Mystery That Has Stymied Quest ...
Newswise (press release) - Feb 7, 2006Newswise The hepatitis C virus (HCV) infects more than 170 million people worldwide and leads to both acute and chronic liver diseases. ...

Intervention urged for hepatitis C victims
Monsters and Critics.com, UK - Feb 6, 2006... Scientists say approximately half of HCV-infected patients will recover with modern anti-viral treatment and success is reportedly even greater among young ...